COVID-19: Vaccine Roll Call

FDA okays vaccination with Pfizer BioNTech vaccine against COVID-19 from age 12 years and above. Once CDC gives a green light, children 12-15 years can receive their COVID-19 shots from their pediatricians. As cases in the US hit a 7-month low and vaccination rates increase this is a major milestone towards getting majority of Americans vaccinated and filling the vaccination gap in the very important segment of the population. Vaccination offers the best scientific promise of getting ahead of the COVID-19 pandemic and society return to normalcy. Currently at least 80% of the US population is within 5 miles of at least one of the 3 vaccines.

All the three vaccines offered in the USA received Emergency Use  Authorization (EUA) following clinical studies that focused on proving their safety, immunogenicity  and above all effectiveness in preventing serious illness, hospitalization and death from COVID-19 infection. A fourth vaccine, NOVAVAX*, is on track to come into use in the USA.